(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.98%.
Adicet Bio's earnings in 2026 is -$98,974,000.On average, 8 Wall Street analysts forecast ACET's earnings for 2026 to be -$57,903,624, with the lowest ACET earnings forecast at -$65,320,733, and the highest ACET earnings forecast at -$53,177,944. On average, 7 Wall Street analysts forecast ACET's earnings for 2027 to be -$42,635,034, with the lowest ACET earnings forecast at -$56,054,730, and the highest ACET earnings forecast at -$35,484,728.
In 2028, ACET is forecast to generate -$34,120,759 in earnings, with the lowest earnings forecast at -$38,440,150 and the highest earnings forecast at -$27,424,485.